MAITE CORBIN: Open Payments
NPI 1275188559 · STERLING, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 21 payments from 11 companies in 2025. Trend: 2023 $605 · 2024 $688 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $138 |
| ALK-Abello, Inc | 2 | $45 |
| Lilly USA, LLC | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| ABBVIE INC. | 1 | $27 |
| Exact Sciences Corporation | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: Rybelsus, NEFFY, MOUNJARO, AIRSUPRA, Wegovy, Ozempic, VOQUEZNA, QULIPTA.
Industry payments across VA — which companies pay providers there.
